keyword
https://read.qxmd.com/read/38630378/sex-related-differences-in-the-clinical-presentation-of-multiple-system-atrophy
#1
JOURNAL ARTICLE
Fabian Leys, Sabine Eschlböck, Nicole Campese, Philipp Mahlknecht, Marina Peball, Georg Goebel, Victoria Sidoroff, Florian Krismer, Roberta Granata, Stefan Kiechl, Werner Poewe, Klaus Seppi, Gregor K Wenning, Alessandra Fanciulli
PURPOSE: To investigate sex-related differences in the clinical presentation of multiple system atrophy (MSA) through a literature review and an analysis of a retrospective cohort. METHODS: The PubMed database was searched for articles including sex-related information in MSA. In a retrospective Innsbruck cohort, we investigated the baseline to last available follow-up clinical-demographic differences between men and women with MSA in a univariate fashion, followed by multivariable binary regression analysis...
April 17, 2024: Clinical Autonomic Research: Official Journal of the Clinical Autonomic Research Society
https://read.qxmd.com/read/38629908/incidence-and-risk-factors-for-non-cardiac-syncope-in-a-cohort-of-patients-addressing-an-accredited-arterial-hypertension-center-the-innocent-study
#2
JOURNAL ARTICLE
Filippo Numeroso, Luca Bottaro, Ali Younes, Andrea Ungar, Aderville Cabassi
BACKGROUND: Hypotensive susceptibility in hypertensive patients could facilitate orthostatic hypotension, syncope and fall. The aim of this study was to identify incidence, clinical form, complications and risk factors for non-cardiac syncope in a cohort of hypertensive patients. METHODS: This is an observational, case-controlled, retrospective study carried out on 168 patients, evaluated at the Hypertension Center of the University Hospital of Parma (Italy). Based on the presence of episodes of syncope during the six months prior to enrolment, we identified cases and controls and then we compared them to personal data, comorbidities, current drug regimens, presence of orthostatic hypotension, office and ambulatory blood pressure monitoring (ABPM) blood pressure (BP) values...
April 17, 2024: Minerva Medica
https://read.qxmd.com/read/38626389/feasibility-study-of-single-photon-emission-computed-tomography-with-iodine-123-labeled-metaiodobenzylguanidine-for-preclinical-evaluation-of-labetalol-as-a-%C3%AE-adrenergic-receptor-blocker
#3
JOURNAL ARTICLE
Yiseul Choi, Eun Sang Lee, Sang-Keun Woo, Kyo Chul Lee, Hye Kyung Chung, Joo Hyun Kang
Among clinically used radiopharmaceuticals, iodine-123 labeled metaiodobenzylguanidine ([123 I]mIBG) serves for diagnosing neuroendocrine tumors and obtaining images of myocardial sympathetic innervation. mIBG, a structural analogue of norepinephrine (NE), a neurotransmitter acting in peripheral and central nerves, follows a pathway similar to NE, transmitting signals through the NE transporter (NET) located at synaptic terminals. It moves through the body without decomposing, enabling noninvasive image evaluation...
April 16, 2024: Molecular Pharmaceutics
https://read.qxmd.com/read/38623485/validity-of-prescription-defined-and-hospital-diagnosed-hypertension-compared-with-self-reported-hypertension-in-denmark
#4
JOURNAL ARTICLE
Kasper Bonnesen, Morten Schmidt
PURPOSE: Hypertension is an important risk factor in cardio-epidemiological research, but data quality remains a concern. We validated different registry-based definitions of hypertension. PATIENTS AND METHODS: The cohort included all first-time responders of the Danish National Health Surveys (2010, 2013, or 2017). Prescription-defined hypertension was defined as ≥1 or ≥2 filled prescriptions of antihypertensive specific drugs in ≥1 or ≥2 different antihypertensive drug classes within 90, 180, or 365 days before survey response...
2024: Clinical Epidemiology
https://read.qxmd.com/read/38621952/-economic-evaluation-of-annao-pills-combined-with-antihypertensive-drugs-in-treatment-of-primary-hypertension-a-study-based-on-decision-tree-model
#5
JOURNAL ARTICLE
Zi-Jia Chen, Xin Cui, Sheng Han, Meng Qiao, Chang-Kuan Fu, Zhi-Fei Wang, Yan-Ming Xie
The purpose of this study was to evaluate the economics of Annao Pills combined with antihypertensive drugs in the treatment of primary hypertension in the Chinese medical setting. TreeAge pro 2018 was used for cost-effect analysis and sensitivity analysis of the two treatment regimens. The intervention time of the simulation model was 2 weeks. The cost parameters were derived from Yaozhi.com, and the effect parameters were based on Meta-analysis of randomized controlled trial(RCT) involving Annao Pills. The experimental group was treated with Annao Pills combined with anti-hypertensive drugs(nifedipine controlled-release tablets + losartan potassium tablets), and the control group was treated with anti-hypertensive drugs(nifedipine controlled-release tablets + losartan potassium tablets)...
March 2024: Zhongguo Zhong Yao za Zhi, Zhongguo Zhongyao Zazhi, China Journal of Chinese Materia Medica
https://read.qxmd.com/read/38619761/impact-of-prior-antihypertensive-treatment-on-covid-19-outcomes-by-active-ingredient
#6
JOURNAL ARTICLE
Rosa María García-Álvarez, Maruxa Zapata-Cachafeiro, Irene Visos-Varela, Almudena Rodríguez-Fernández, Samuel Pintos-Rodríguez, Maria Piñeiro-Lamas, Teresa M Herdeiro, Adolfo Figueiras, Angel Salgado-Barreira
OBJECTIVES: To assess the impact of prior chronic treatment with angiotensin-converting enzyme inhibitors (ACEIs)/ angiotensin-receptor blockers (ARBs), both as a group and by active ingredient, on severity (risk of hospitalization and mortality), progression of and susceptibility to COVID-19. METHODS: We conducted a multiple population-based case-control study in Galicia (north-west Spain). The study data were sourced from medical, administrative and clinical databases...
April 15, 2024: Inflammopharmacology
https://read.qxmd.com/read/38616460/a-novel-proof-of-concept-radiofrequency-renal-denervation-strategy-to-improve-procedural-efficiency-12-month-results-from-the-spyral-dystal-pilot-study
#7
JOURNAL ARTICLE
Andrew S P Sharp, David E Kandzari, Raymond R Townsend, Kazuomi Kario, Felix Mahfoud, Michael A Weber, Roland E Schmieder, Konstantinos Tsioufis, Michael Böhm, James W Choi, Minglei Liu, Vanessa DeBruin, David P Lee
BACKGROUND: Catheter-based renal sympathetic denervation (RDN) reduced blood pressure (BP) in multiple randomized sham-controlled trials of patients with uncontrolled hypertension (HTN). We tested proof-of-concept for a more selective treatment strategy, exclusively targeting these areas to improve the efficiency of the procedure. METHODS: The SPYRAL DYSTAL Pilot study was designed to mirror the SPYRAL HTN-OFF MED Pivotal study, enabling comparison with a propensity score adjusted active-control group...
April 10, 2024: Cardiovascular Revascularization Medicine: Including Molecular Interventions
https://read.qxmd.com/read/38616362/associations-between-hypertension-angiotensin-converting-enzyme-inhibitors-and-physical-performance-in-very-old-adults-results-from-the-ilsirente-study
#8
JOURNAL ARTICLE
H J Coelho-Junior, R Calvani, M Tosato, A Álvarez-Bustos, F Landi, A Picca, E Marzetti
BACKGROUND: Results regarding the associations between hypertension-related parameters and physical performance in older adults are conflicting. A possible explanation for these divergent results is that investigations may not have adjusted their analyses according to the use of angiotensin-converting enzyme inhibitors (ACEIs). OBJECTIVES: To examine the associations between hypertension-related parameters, ACEI use, and a set of physical performance tests in very old adults...
2024: Journal of Frailty & Aging
https://read.qxmd.com/read/38616212/systematic-review-article-new-drug-strategies-for-treating-resistant-hypertension-the-importance-of-a-mechanistic-personalized-approach
#9
REVIEW
Giulia Nardoianni, Barbara Pala, Alessandra Scoccia, Massimo Volpe, Emanuele Barbato, Giuliano Tocci
Resistant hypertension (RHT) is characterized by persistently high blood pressure (BP) levels above the widely recommended therapeutic targets of less than 140/90 mmHg office BP, despite life-style measures and optimal medical therapies, including at least three antihypertensive drug classes at maximum tolerated dose (one should be a diuretic). This condition is strongly related to hypertension-mediated organ damage and, mostly, high risk of hospitalization due to hypertension emergencies or acute cardiovascular events...
April 14, 2024: High Blood Pressure & Cardiovascular Prevention: the Official Journal of the Italian Society of Hypertension
https://read.qxmd.com/read/38610145/hypertension-medication-and-medicare-beneficiaries-prescription-drug-coverage-satisfaction-and-medication-non-adherence-among-older-adults
#10
JOURNAL ARTICLE
Jeong-Hui Park, Kiyoung Kim, Mar Medina, Boon Peng Ng, Matthew Lee Smith, Okeoghene Marcel Edafetanure-Ibeh, Jongwha Chang
Hypertension is so prevalent and requires strict adherence to medications to prevent further disease or death, but there is no study examining factors related to prescription drug non-adherence among 65 years old and older. This study aims to assess the likelihood of medication nonadherence among patients based on factors such as age, race, and socioeconomic status, with the goal of identifying strategies to enhance medication adherence and mitigate associated health risks. Using the 2020 Medicare Current Beneficiary Survey Public Use File to represent nationwide Medicare beneficiaries (unweighted n = 3917, weighted n = 27,134,782), medication non-adherence was related to multiple independent variables (i...
March 26, 2024: Healthcare (Basel, Switzerland)
https://read.qxmd.com/read/38609108/drug-related-nitrosogenesis-photocarcinogenesis-and-oncopharmacogenesis-of-nodular-melanoma-a-case-related-analysis-concerning-the-polycontamination-of-the-polymedication-with-valsartan-hydrochlorothiazide-and-bisoprolol
#11
JOURNAL ARTICLE
G Tchernev, V Broshtilova, L Ivanov, A Alexandrov, N Smilov, S Kordeva
Despite the fact that the pathogenesis of cutaneous melanoma is shrouded in mystery, factors that have been neglected or unnoticed until now have come to the attention in recent years, and in all likelihood, they could also be pivotal. These factors, known as nitrosamines or NDSRIs, are characterized by high carcinogenic and mutagenic potency, and some of them have demonstrated these properties to human DNA as well. Unfortunately, these ingredients also turn up as contaminants in about 300 of the most widely distributed drugs worldwide...
February 2024: Georgian Medical News
https://read.qxmd.com/read/38608541/evaluation-of-photobiomodulation-in-the-salivary-production-of-patients-with-hyposalivation-induced-by-antihypertensive-drugs-a-blind-randomized-controlled-clinical-trial
#12
JOURNAL ARTICLE
Maria Lucia Zarvos Varellis, Sandra Kalil Bussadori, Vanessa Christina Santos Pavesi, Benedito Jorge Pereira, Cícero Dayves Silva Bezerra, Felipe Gonçalves Silva, Gabriela Silva Castro, Rafaela Campos Teixeira Afonso, Valdomiro Franscisco Barbosa Filho, Alessandro Melo Deana
BACKGROUND: Arterial hypertension is a systemic condition that affects about 35% of the world population. The drugs that are used for its control can produce hyposalivation. This work evaluated the effect of photobiomodulation on salivary flow rate, salivary pH, total protein concentration, and calcium concentration in individuals using antihypertensive medications. MATERIAL AND METHODS: 41 subjects were randomly allocated in one of two groups: control (placebo) and photobiomodulation...
March 22, 2024: Complementary Therapies in Clinical Practice
https://read.qxmd.com/read/38607629/depression-onset-after-a-spouse-s-cardiovascular-event
#13
JOURNAL ARTICLE
Toshiaki Komura, Yusuke Tsugawa, Naoki Kondo, Kosuke Inoue
IMPORTANCE: Although cardiovascular disease (CVD) is a known risk factor for depression, evidence is lacking regarding whether and to what extent a spouse's CVD is associated with the subsequent mental health of individuals. OBJECTIVE: To examine the association between CVD onset in spouses and subsequent depression. DESIGN, SETTING, AND PARTICIPANTS: This cohort study examined 277 142 matched married couples enrolled in the Japan Health Insurance Association health insurance program between April 2015 and March 2022, covering approximately 40% of the working-age population in Japan...
April 1, 2024: JAMA Network Open
https://read.qxmd.com/read/38607208/correlation-between-the-severity-of-coronary-artery-disease-and-retinal-artery-disease-and-the-therapeutic-effect-of-captopril
#14
JOURNAL ARTICLE
Xing Ge, Xiaoli Liu, Tienan Sun, Xinxiao Gao, Hongya Han, Yujie Zhou
OBJECTIVE: Investigate the Correlation Between the Severity of Coronary Artery Disease and Retinal Artery Disease, and assess the Efficacy of Angiotensin-Converting Enzyme Inhibitors (ACEIs) Application. METHODS: One hundred patients diagnosed with primary hypertension at our hospital were chosen for the study. All patients underwent dual-source 64-layer spiral CT coronary angiography and fundus photography examination. Based on the extent of coronary artery stenosis, the patients were divided into Group A, Group B, Group C, and Group D...
April 12, 2024: Alternative Therapies in Health and Medicine
https://read.qxmd.com/read/38605140/impact-of-renal-denervation-on-quality-of-life-how-does-renal-denervation-contribute-to-improving-hypertension-treatment-affected-by-poor-medication-adherence
#15
REVIEW
Keisuke Okamura, Hideaki Shimada, Keisuke Imazato, Hideto Sako, Akihiro Udo, Kenichiro Taniguchi, Shogo Morisaki, Ichiro Imamura, Hidenori Urata, Hisatomi Arima, Shin-Ichiro Miura
The US Food and Drug Administration has approved renal denervation (RDN) as a new treatment option for hypertension (HT) because it not only has antihypertensive effects but also improves the quality of blood pressure (BP) reduction. RDN is expected to be increasingly used in clinical practice in the future. This review summarizes the impact of RDN on quality of life (QOL). Although the treatment of HT aims to improve life prognosis, the use of antihypertensive agents can impair QOL because of adverse effects and lifestyle changes associated with long-term medication use...
April 11, 2024: Hypertension Research: Official Journal of the Japanese Society of Hypertension
https://read.qxmd.com/read/38604640/do-patients-with-type-2-diabetes-mellitus-included-in-randomised-clinical-trials-differ-from-general-practice-patients-a-cross-sectional-comparative-study
#16
JOURNAL ARTICLE
Amandine Dugard, Bruno Giraudeau, Clarisse Dibao-Dina
OBJECTIVES: To compare the characteristics of patients with type 2 diabetes mellitus in general practice and those included in randomised controlled trials on which clinical practice guidelines are based. DESIGN: Cross-sectional comparative study. SETTING: We asked 45 general practitioners from three French Departments to identify the 15 patients with type 2 diabetes mellitus they most recently saw in consultation. In parallel, we selected randomised controlled trials included in the Cochrane systematic review on which the clinical practice guidelines for type 2 diabetes mellitus were based...
April 11, 2024: BMJ Open
https://read.qxmd.com/read/38602174/nebivolol-an-antihypertensive-agent-has-new-application-in-inhibiting-melanoma
#17
JOURNAL ARTICLE
Shuping Yang, Zhi Li, Jiamei Yi, Mingyue Pan, Weiling Cao, Jing Ma, Peng Zhang
Repurposing existing drugs for cancer therapy has become an important strategy because of its advantages, such as cost reduction, effect and safety. The present study was designed to investigate the antimelanoma effect and possible mechanisms of action of nebivolol, which is an approved and widely prescribed antihypertensive agent. In this study, we explored the effect of nebivolol on cell proliferation and cell activity in melanoma in vitro and the potential antimelanoma mechanism of nebivolol through a series of experiments, including the analysis of the effects with regard to cell apoptosis and metastasis...
April 11, 2024: Anti-cancer Drugs
https://read.qxmd.com/read/38601903/differences-in-antihypertensive-medication-prescription-profiles-between-2009-and-2021-a-retrospective-cohort-study-of-cartagene
#18
JOURNAL ARTICLE
Victoria Ivensky, Pitchou Zonga, Gabriel Dallaire, Louis-Charles Desbiens, Annie-Claire Nadeau-Fredette, Guy Rousseau, Rémi Goupil
BACKGROUND: Although blood pressure (BP) control is critical to prevent cardiovascular diseases, hypertension control rates in Canada are in decline. OBJECTIVE: To assess this issue, we sought to evaluate the differences in antihypertensive medication prescription profiles in the province of Quebec between 2009 and 2021. DESIGN: This is a retrospective cohort study. SETTING: We used data from the CARTaGENE population-based cohort linked to administrative health databases...
2024: Canadian Journal of Kidney Health and Disease
https://read.qxmd.com/read/38597552/testosterone-deficiency-in-hypertensive-men-prevalence-and-associated-factors
#19
JOURNAL ARTICLE
Leandra Analia Freitas Negretto, Nelson Rassi, Leonardo Ribeiro Soares, Amanda Bueno Carvalho Saraiva, Maria Emília Figueiredo Teixeira, Luciana da Ressurreição Santos, Ana Luiza Lima Souza, Paulo Cesar B Veiga Jardim, Weimar Kunz Sebba Barroso de Souza, Thiago de Souza Veiga Jardim
BACKGROUND: Testosterone deficiency (TD) is a prevalent condition in our midst and still very neglected. Arterial hypertension (AH) is one of the possible associated factors. OBJECTIVES: To determine the prevalence of TD in a hypertensive male population and the factors associated with its occurrence, such as age, time since hypertension diagnosis, number of antihypertensive classes, body mass index (BMI), diabetes, dyslipidemia, chronic kidney disease (CKD), positive symptoms of TD (positive ADAM questionnaire) and use of spironolactone...
2024: Arquivos Brasileiros de Cardiologia
https://read.qxmd.com/read/38597066/the-current-position-of-%C3%AE-blockers-in-hypertension-guidelines-and-clinical-practice
#20
REVIEW
Felix Mahfoud, Jiguang Wang, Saumitra Ray
The benefits of improved clinical outcomes through blood pressure (BP) reduction have been proven in multiple clinical trials and meta-analyses. The new (2023) guideline from the European Society of Hypertension (ESH) includes β-blockers within five main classes of antihypertensive agents suitable for initiation of antihypertensive pharmacotherapy and for combination with other antihypertensive agents. This is in contrast to the 2018 edition of ESH guidelines that recommended β-blockers for use primarily in patients with compelling indications such as cardiovascular comorbidities, e...
2024: Current Medical Research and Opinion
keyword
keyword
82774
1
2
Fetch more papers »
Fetching more papers... Fetching...
Remove bar
Read by QxMD icon Read
×

Save your favorite articles in one place with a free QxMD account.

×

Search Tips

Use Boolean operators: AND/OR

diabetic AND foot
diabetes OR diabetic

Exclude a word using the 'minus' sign

Virchow -triad

Use Parentheses

water AND (cup OR glass)

Add an asterisk (*) at end of a word to include word stems

Neuro* will search for Neurology, Neuroscientist, Neurological, and so on

Use quotes to search for an exact phrase

"primary prevention of cancer"
(heart or cardiac or cardio*) AND arrest -"American Heart Association"

We want to hear from doctors like you!

Take a second to answer a survey question.